Diabetes care, drug-delivery power Becton Dickinson’s beat

11/04/2014 majac Your Health Matters

(Reuters) – Medical equipment maker Becton Dickinson & Co reported better-than-expected profit and revenue, helped by strong sales in its diabetes care and drug-delivery businesses. Becton said it expected adjusted earnings from continuing operations to be between $6.76 and $6.83 per share for the year ending September 2015. Analysts on average were expecting $6.70 per share, according to Thomson Reuters I/B/E/S. …
Go to Source

Share on Facebook

Save